Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07417605
Eligibility Criteria:
Inclusion Criteria:
* Adult patient ≥ 18 years of age
* Presenting with head and neck squamous cell carcinoma
* Completed curative treatment with external radiation therapy
* Eligible for dynamic LAFOV FDG-PET scan for therapeutic evaluation at 3 months
* Having given consent for the end-of-treatment consultation
Exclusion Criteria:
* Hypersensitivity to 18F-FDG or other excipients contained in the contrast agent
* Pregnancy or breastfeeding
* History of treated upper gastrointestinal tract cancer
* Other histology
* Incomplete RTE treatment regimen
* Refusal to participate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07417605
Study Brief:
Protocol Section:
NCT07417605